GCG and type 2 diabetes mellitus: To demonstrate that this nanosystem represents a plausible alternative to current strategies for the oral delivery of incretin peptides in the treatment of T2DM, we conducted a chronic/long-term treatment consisting of a 5-week daily administration protocol.